USPTO serial 99086674
DEYA
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- ANDERSON, ELIZABETH C
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with DEYA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $498*
Plus Government fees of $250
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Philadelphia, PA, US
Philadelphia, PA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas J. Perkowski
Thomas J. Perkowski Thomas J. Perkowski, ESQ., PC6 Thorndal CircleSuite 206Darien CT, CT 06820-5415Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer graphics software systems and computer hardware for providing programs and services that support automated and/or AI-assisted recognition of ocular diseases (OD), including dry eye disease (DED) syndrome and other anterior segment and posterior segment type ocular diseases; Downloadable computer graphics software systems and computer hardware for providing programs and services for remotely monitoring and analyzing digital images of the eyes of human subjects captured using visible-wavelength and/or infra-red wavelength illumination sources and digital camera systems, for the purpose of AI-supported ocular disease prescription, treatment and/or management; Downloadable computer graphics software systems and computer hardware for providing programs and services to patients using mobile smart phone systems, each equipped with an integrated digital camera system, supporting automated and/or AI-assisted ocular disease prescription, treatment and/or management ; Downloadable computer graphics software systems and computer hardware for providing programs and services to ophthalmologists, optometrists, and other healthcare practitioners and providers, supporting automated and/or AI-assisted ocular disease prescription, treatment and/or management; Downloadable computer graphics software systems and computer hardware for providing programs and services to ophthalmologists, optometrists, and other healthcare practitioners and providers, supporting the remote monitoring, diagnosis and/or treatment of the human eyes of others involved in human activity in diverse fields including ophthalmology, telemedicine, telehealth, automotive, aerospace, military, industry, construction, education, business, home-entertainment, recreation, video-gaming, and VR/AR experience; Standalone and/or mobile kiosk systems for remotely monitoring and analyzing digital images of the eyes of human subjects captured using visible-wavelength and/or infra-red wavelength illumination sources and digital camera systems, and processing the digital images using automated and/or AI-assisted machine-vision image processing systems, supporting remote monitoring, diagnosis and treatment of the human eyes of others | ACTIVE | — |
| 042 | Platform as a service (PaaS) featuring computer software platforms and machine-vision systems for providing programs and services to ophthalmic specialists, including ophthalmologists, optometrists, and other healthcare practitioners and providers, healthcare firms and others in the field of automated and/or AI-assisted ocular disease prescription, treatment and management; Platform as a service (PaaS) featuring computer software platforms and machine-vision systems for providing programs and services for remotely monitoring and analyzing digital images of the eyes of human subjects captured using visible-wavelength and/or infra-red wavelength illumination sources and digital camera systems, and processing the digital images using automated and/or AI-assisted machine-vision image processing system, so as to provide automated and/or AI-assisted recognition of ocular diseases (OD), including dry eye disease (DED) syndrome; Platform as a service (PaaS) featuring computer software platforms and machine-vision systems for providing programs and services supporting standalone and/or mobile kiosk systems for remotely monitoring and analyzing digital images of the eyes of human subjects and processing the digital images using automated and/or AI-assisted machine-vision image processing systems ; Platform as a service (PaaS) featuring computer software platforms and machine-vision systems for providing programs and services to ophthalmologists, optometrists, and other healthcare practitioners and providers, supporting the remote monitoring, diagnosis and/or treatment of the human eyes of others involved in human activity in diverse fields including ophthalmology, telemedicine, telehealth, automotive, aerospace, military, industry, construction, education, business, home-entertainment, recreation, video-gaming, and VR/AR experience ; Cloud-based digital platform as a service (PaaS) featuring computer software platforms and machine-vision systems for providing programs and services supporting ophthalmic diagnostic, treatment, and eyecare management services through a suite of integrated tools supporting the examination, diagnosis and treatment of the eyes and vision system in human beings, providing ophthalmologists, optometrists, and other healthcare practitioners and providers with services for onboarding patients to the platform, providing remote eye examination services to patients using mobile phones with digital camera systems, and providing case management tracking services, supporting remote patient eyecare management. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 15, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 15, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 15, 2026 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jun 15, 2026 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jun 15, 2026 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 15, 2026 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 15, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 15, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 11, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 11, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 16, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 16, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 15, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 16, 2025 | NWAP | NEW APPLICATION ENTERED | — |